dactinomycin and glucosaminylmuramyl-2-alanine-d-isoglutamine

dactinomycin has been researched along with glucosaminylmuramyl-2-alanine-d-isoglutamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andronova, TM; Blokhin, DY; Ivanov, PK; Khaidukov, SV; Komaleva, RL; Makarov, EA; Nesmeyanov, VA; Petrova, EE; Simonova, MA; Valyakina, TI	1

Other Studies

1 other study(ies) available for dactinomycin and glucosaminylmuramyl-2-alanine-d-isoglutamine

Article	Year
Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells. International immunopharmacology, 2006, Volume: 6, Issue:9 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Death; Cells, Cultured; Cisplatin; Cytotoxicity, Immunologic; Dactinomycin; Drug Therapy, Combination; Humans; L Cells; Mice; Neoplasms; Tumor Necrosis Factor-alpha; U937 Cells	2006

Article

Year

Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.

International immunopharmacology, 2006, Volume: 6, Issue:9

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Death; Cells, Cultured; Cisplatin; Cytotoxicity, Immunologic; Dactinomycin; Drug Therapy, Combination; Humans; L Cells; Mice; Neoplasms; Tumor Necrosis Factor-alpha; U937 Cells

2006